The store will not work correctly when cookies are disabled.
2-[2-(5-guanidinotetrazol-2-yl)ethyl]tetrazole-5-carboxamidine
ID: ALA4577601
PubChem CID: 155564670
Max Phase: Preclinical
Molecular Formula: C6H11N13
Molecular Weight: 265.25
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(N)Nc1nnn(CCn2nnc(C(=N)N)n2)n1
Standard InChI: InChI=1S/C6H11N13/c7-3(8)4-12-16-18(14-4)1-2-19-15-6(13-17-19)11-5(9)10/h1-2H2,(H3,7,8)(H4,9,10,11,15)
Standard InChI Key: KZOGUYBKZQZUKD-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
7.7125 -19.1368 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0465 -18.6525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3024 -17.8649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.1226 -17.8649 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3784 -18.6525 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.1753 -18.8659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7587 -18.2824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5557 -18.4958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.1920 -17.9752 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.8843 -18.4252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6710 -19.2215 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8486 -19.2623 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.6812 -18.2118 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8947 -17.4149 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.2647 -18.7953 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2497 -18.8659 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6662 -18.2824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8693 -18.4958 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8796 -17.4855 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 1 0
5 6 1 0
6 7 1 0
7 8 1 0
9 8 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 8 1 0
10 13 1 0
13 14 2 0
13 15 1 0
2 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 265.25 | Molecular Weight (Monoisotopic): 265.1260 | AlogP: -3.05 | #Rotatable Bonds: 5 |
Polar Surface Area: 198.97 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 5 |
#RO5 Violations: ┄ | HBA (Lipinski): 13 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: ┄ | CX Basic pKa: 5.52 | CX LogP: -0.93 | CX LogD: -0.94 |
Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.27 | Np Likeness Score: -1.29 |